Textbook of Medical Physiology

significant part 2 of the resistance to blood flow is in the upstream small Endothelial cells arteries. Soluble guanylate cyclase NO synthesis and release from endothelial cells are also stimulated by some vasoconstrictors, such as angio- cGTP cGMP tensin II, which bind to specific receptors on endothelial Relaxation cells. The increased NO release protects against excessive Vascular smooth muscle vasoconstriction. Figure 17- 6. Nitric oxide synthase (eNOS) enzyme in endothelial cells When endothelial cells are damaged by chronic hyper- synthesizes nitric oxide (NO) from arginine and oxygen. NO activates tension or atherosclerosis, impaired NO synthesis may soluble guanylate cyclases in vascular smooth muscle cells, resulting contribute to excessive vasoconstriction and worsening in conversion of cyclic guanosine triphosphate (cGTP) to cyclic guano- sine monophosphate (cGMP), which ultimately causes the blood ves- of the hypertension and endothelial damage. If untreated, sels to relax. this may eventually cause vascular injury and damage to vulnerable tissues such as the heart, kidneys, and brain. Even before NO was discovered, clinicians used nitro- Control of Tissue Blood Flow: glycerin, amyl nitrate, and other nitrate derivatives to treat Endothelium-D erived Relaxing or patients who had angina pectorisâ€”that is, severe chest Constricting Factors pain caused by ischemia of
